Activist 13D/13G Filings - Carlyle Group Inc. (CG)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, 4, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-13
4:55 pm
Sale
13GThe Carlyle Group Inc.
CG
VANGUARD GROUP INC24,876,188
6.89%
-76,681decrease
(-0.31%)
View
2024-02-12
6:00 pm
Sale
13DJasper Therapeutics, Inc.
JSPR
Carlyle Group Inc.
CG
1,066,189
7.1%
-7,695,702decrease
(-87.83%)
View
2024-02-12
5:46 pm
Sale
13GZoomInfo Technologies Inc.
ZI
Carlyle Group Inc.
CG
35,244,474
9%
-1,417,995decrease
(-3.87%)
View
2024-02-12
5:45 pm
Sale
13GMKS Instruments, Inc.
MKSI
Carlyle Group Inc.
CG
0
0%
-8,482,732decrease
(Position Closed)
View
2024-02-12
4:36 pm
Purchase
13GPhathom Pharmaceuticals, Inc.
PHAT
Carlyle Group Inc.
CG
3,496,808
6.1%
561,702increase
(+19.14%)
View
2024-02-12
4:31 pm
Unchanged
13GHilleVax, Inc.
HLVX
Carlyle Group Inc.
CG
1,838,486
3.8%
0
(Unchanged)
View
2024-02-12
11:22 am
Sale
13GThe Carlyle Group Inc.
CG
MORGAN STANLEY
MS
10,485,962
2.9%
-12,926,684decrease
(-55.21%)
View
2024-02-09
6:14 pm
Purchase
13GThe Carlyle Group Inc.
CG
Capital World Investors20,008,088
5.5%
17,791,088increase
(+802.48%)
View
2024-02-07
4:31 pm
Purchase
13DAdicet Bio, Inc.
ACET
Carlyle Group Inc.
CG
3,060,292
4.1%
907,333increase
(+42.14%)
View
2024-01-25
1:48 pm
Purchase
13GThe Carlyle Group Inc.
CG
BlackRock Inc.
BLK
31,155,048
8.6%
31,155,048increase
(New Position)
View
2024-01-03
4:15 pm
Purchase
13DCommScope Holding Company, Inc.
COMM
Carlyle Group Inc.
CG
42,257,593
16.6%
2,789,051increase
(+7.07%)
View
2023-10-16
4:30 pm
Purchase
13DSoleno Therapeutics, Inc.
SLNO
Carlyle Group Inc.
CG
2,893,615
9.99%
1,326,368increase
(+84.63%)
View
2023-10-03
4:05 pm
Purchase
13DSoleno Therapeutics, Inc.
SLNO
Carlyle Group Inc.
CG
1,567,247
9.99%
339,930increase
(+27.70%)
View
2023-09-22
4:22 pm
Purchase
13GComplete Solaria, Inc.
CSLR
Carlyle Group Inc.
CG
2,745,879
5.7%
2,745,879increase
(New Position)
View
2023-09-14
4:05 pm
Purchase
13DCarlyle Credit Income Fund
CCIF
Carlyle Group Inc.
CG
4,785,628
41%
1,269,537increase
(+36.11%)
View
2023-08-30
5:19 pm
Purchase
13DCarlyle Credit Income Fund
CCIF
Carlyle Group Inc.
CG
3,516,091
33.8%
2,672,060increase
(+316.58%)
View
2023-08-18
4:16 pm
Unchanged
13DeFFECTOR Therapeutics, Inc.
EFTR
Carlyle Group Inc.
CG
4,829,891
7.8%
0
(Unchanged)
View
2023-08-18
4:15 pm
Purchase
13DSoleno Therapeutics, Inc.
SLNO
Carlyle Group Inc.
CG
1,227,317
12.3%
1,227,317increase
(New Position)
View
2023-08-02
5:01 pm
Sale
13DVera Therapeutics, Inc.
VERA
Carlyle Group Inc.
CG
1,872,764
4.2%
-544,073decrease
(-22.51%)
View
2023-07-17
4:40 pm
Sale
13DCarlyle Credit Income Fund
CCIF
Carlyle Group Inc.
CG
844,031
8.1%
-2,874,225decrease
(-77.30%)
View
Goto 0, 1, 2, 3, 4, Next